NCT00045370View on ClinicalTrials.gov

Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

temsirolimus

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00045370 - Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter